Table 3.
Disease | Therapeutic drug | CYP450 enzymes that affect drug metabolism |
---|---|---|
Malaria | Artemether | CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, CYP3A5, |
Lumefantrine | CYP2D6, CYP3A4, CYP3A5 | |
Amodiaquine | CYP1A1, CYP1B1, CYP2C8 | |
Mefloquine | CYP3A4, CYP3A5 | |
Chloroquine | CYP2C8, CYP2D6, CYP3A4, CYP3A5 | |
Sulfadoxine-pyrimethamine | CYP2C9, CYP2D6 | |
Primaquine | CYP1A1, CYP1A2, CYP3A4, CYP3A5, | |
Quinine | CYP1A1, CYP1A2, CYP3A5 | |
HIV | Efavirenz | CYP2B6, CYP3A4, CYP3A5 |
Saquinavir | CYP3A4, CYP3A5 | |
Abacavir | No CYP450 enzyme | |
Maraviroc | CYP3A4, CYP3A5 | |
Nevirapine | CYP2B6 | |
Indinavir | CYP3A4, CYP3A5 | |
Nelfinavir | CYP3A4, CYP3A5 | |
Ritonavir | CYP3A4, CYP3A5 | |
Lopinavir | CYP3A4, CYP3A5 | |
Tuberculosis | Isoniazid | CYP1A2,CYP2C19,CYP2E1 |
Rifampin (Rifadin, Rimactane) | CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP3A4, CYP3A5 | |
Ethambutol (Myambutol) | CYP2C9, CYP2C19, CYP2E1 | |
Pyrazinamide | CYP1A2, CYP3A4 | |
Leishmaniasis | Pentostam | No CYP450 enzyme |
Glucantime | No information | |
Pentamidine | CYP1A1, CYP1A2, CYP2C8, CYP2C19, CYP2D6, CYP3A4, CYP3A5, CYP4A11 | |
Amphotericin B | No CYP450 enzyme | |
Ketoconazole (on trial) | CYP1A1, CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, CYP3A7 | |
Human African Trypanosomiasis | Pentamidine (for Trypanosoma brucei gambiense) | CYP1A1, CYP1A2, CYP2C8, CYP2C19, CYP2B6, CYP3A4, CYP3A5, CYP4A11, |
Suramin | No CYP450 enzyme | |
Melarsoprol | No information | |
Eflornithine | No information | |
Nifurtimox | No information | |
South American Trypanosomiasis (Chagas disease) | Benzimidazole | No CYP450 enzyme |
Nifurtimox | No information | |
Leprosy | Rifampin | CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP3A4, CYP3A5 |
Dapsone | CYP2C8, CYP3A4, CYP3A5 | |
Clofazimine | CYP3A4, CYP3A5 | |
Lymphatic filariasis | Diethylcarbamazine (DEC) | No CYP450 enzyme |
Information has been compiled from the literature and from online databases.